dc.creatorCampino, Carmen
dc.creatorSzecowka, Jaroslaw
dc.creatorMichelsen, Harold
dc.creatorSerón Ferré, María
dc.date.accessioned2019-01-29T14:49:19Z
dc.date.available2019-01-29T14:49:19Z
dc.date.created2019-01-29T14:49:19Z
dc.date.issued1990
dc.identifierJournal of Clinical Endocrinology and Metabolism, Volumen 70, Issue 3, 2018, Pages 601-605
dc.identifier19457197
dc.identifier0021972X
dc.identifier10.1210/jcem-70-3-601
dc.identifierhttps://repositorio.uchile.cl/handle/2250/160814
dc.description.abstractTo explain frequent discordances between serum GH levels and clinical manifestation of acromegaly, we investigated the possibility that certain immunoglobulins G (IgGs) might be responsible for the displacement of [125I]human (h) GH in the hGH RIA. We incubated dilute sera from seven active acromegalics (basal immunoreactive hGH, 22–313 μg/L) with rat adipocyte plasma membranes adsorbed on polystyrene plates. IgGs that bound to GH receptor sites in the absence and presence of 250 nM hGH (for nonspecific binding) were detected using anti-hlgG (Fc-specific) antibody conjugated with alkaline phosphatase. In this system two of the seven sera studied tested positive for IgGs against GH-binding sites (serum 4 in 1:400 dilution, and serum 7 in 1:10 dilution). We studied further the serum with the highest titer. On Sephadex G-100, most of the GH-like immunoreactivity (assayed by RIA) present in serum 4 coeluted with IgGs (assayed by immunodiffussion) as a high mol wt (≥ 150 kDa) component. To
dc.languageen
dc.rightshttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceJournal of Clinical Endocrinology and Metabolism
dc.subjectEndocrinology, Diabetes and Metabolism
dc.subjectBiochemistry
dc.subjectEndocrinology
dc.subjectClinical Biochemistry
dc.subjectBiochemistry (medical)
dc.titleCertain large forms of circulating immunoreactive human growth hormone are in fact immunoglobulins
dc.typeArtículo de revista


Este ítem pertenece a la siguiente institución